Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 

MRI is trending to low field magnets :
reduced costs will lead to this change 
AI will close the gap to high field 
only in remote areas 
is only temporary 
never 




 
MRI News Service:
'Gadolinium'  p6
SEARCH NEWS FOR   
 
Result: Searchterm 'Gadolinium' found in 71 news
Result Pages
...
More Results: Database  (66)  Resources  (6)  Forum  (17)  
News     News Refinements:  Contrast Agents  Devices  Financial  
TOSHIBA'S CONTRAST-FREE MRA TECHNIQUES IMPROVE PATIENT SAFETY AT LITTLE COMPANY OF MARY
''In response to concern over gadolinium-based contrast agents, Little Company of Mary, a not-for-profit Catholic community hospital in Evergreen Park, Ill., wanted to provide the highest quality and safest MRA procedures to its patients. To accomplish ...'
Thursday, 25 February 2010   by medical.toshiba.com
Contrast Agent With MRI Improves Detection of Lymph Nodes Metastases
''Addition of the contrast agent gadolinium during magnetic resonance imaging (MRI) for primary tumor assessment improved accuracy for detecting lymph node metastases, according to a new study published online February 1 in the Journal of the National ...'
Monday, 1 February 2010   by www.sciencedaily.com
Adverse Reactions from Gadolinium-Based Contrast Agents Used During MRI Rarely Occur, Study Suggests
''Acute adverse reactions from gadolinium-based contrast agents used during magnetic resonance imaging (MRI) to help improve the information seen on the images rarely occur, according to a study published in the February issue of the American Journal of ...'
Wednesday, 20 January 2010   by www.healthcanal.com
Response to Recent Press Concerning Legal Actions Taken by GE Healthcare in the UK
''GE Healthcare has promoted a vigorous scientific debate about the safety of Gadolinium Based Contrast Agents (GBCAs), including Omniscan™ and we reject any suggestion to the contrary. Like the many other scientists who have contributed to this ...'
Sunday, 20 December 2009   by newsroom.gehealthcare.com
The US Drug Watchdog Initiates a National Investigation of Gadolinium-Medical MRI's- Kidney Disease and NSF
''The US Drug Watchdog is launching a national investigation into the Gadolinium based dye used in MRI imaging, out of fear that thousands of US citizens with kidney disease, who had an MRI or other scan with contrast, may now have an incurable medical ...'
Monday, 14 December 2009   by www.earthtimes.org
European Medicines Agency makes recommendations to minimise risk of nephrogenic systemic fibrosis with gadolinium-containing contrast agents
''The European Medicines Agency (EMEA) has adopted a set of recommendations aimed at minimising the risk of nephrogenic systemic fibrosis (NSF) with gadolinium-containing contrast agents in patients at risk of developing the ...'
Friday, 20 November 2009   by www.ema.europa.eu
Covidien Adds Kidney Disease Risk to its Imaging Agent
''Drug and medical device company Covidien said Nov. 9 that it is changing the label of its imaging agent Optimark to indicate that it is dangerous for use in patients with severe renal impairment. Optimark gadoversetamide injection is a ...'
Wednesday, 11 November 2009   by www.renalbusiness.com
December 8, 2009: Joint Meeting of the Cardiovascular and Renal Drugs and Drug Safety and Risk Management Advisory Committee Meeting Announcement
''The committees will discuss safety considerations related to FDA approved gadolinium-based contrast agents used with magnetic resonance imaging (MRI) scans. An MRI is a medical imaging technique that does not require x-rays. These scans outline the ...'
Thursday, 15 October 2009   by www.fda.gov
Hybrid metal and organic nanoparticles for targeting, imaging, and treating cancer
''Using a set of three biocompatible polymers and a nanoparticle containing gadolinium, a team of investigators at the Colorado School of Mines has created a nanoparticle platform that has the potential to target, image, and treat cancer. Gadolinium ...'
Monday, 27 April 2009   by www.news-medical.net
Questions and Answers on Gadolinium-Based Contrast Agents
''Since December 2006, FDA has continued to investigate reports of nephrogenic systemic fibrosis (NSF) in patients who received gadolinium-based contrast agents (GBCAs) to help define risk factors for NSF. In addition, the FDA has requested the ...'
Friday, 9 January 2009   by www.fda.gov
News     News Refinements:  Contrast Agents  Devices  Financial  
Radiology News Open this link in a new window Ultrasound Imaging News Open this link in a new window
Result Pages
...
What is a cynic? A man who knows the price of everything and the value of nothing.
- Oscar Wilde
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 15 May 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]